Relapse in stage I(E) diffuse large B‐cell lymphoma

Despite a general favourable outcome in limited stage diffuse large B‐cell lymphoma (DLBCL), relapses occur in about 10 to 20% of patients. Prognostic models only partially identify patients at risk for relapse. Moreover, it is not known whether the outcome after such a relapse is similar to the out...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hematol Oncol
Main Authors: Nijland, Marcel, Boslooper, Karin, van Imhoff, Gustaaf, Kibbelaar, Robbie, Joosten, Peter, Storm, Huib, van Roon, Eric N., Diepstra, Arjan, Kluin‐Nelemans, Hanneke C., Hoogendoorn, Mels
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947732/
https://ncbi.nlm.nih.gov/pubmed/29083044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados